News from Express PharmaFollowNews from Express PharmaYour destination for news from Express Pharma. See how Express Pharma’s media bias impacts the breaking news stories of today.We’ve aggregated 210 of Express Pharma’s headlines and news stories over the past 3 months. Ground News rates Express Pharma’s media bias as . . Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check. Express Pharma’s factuality rating is Unknown. Ground News calculates this rating using a combination of the fact and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.Follow Your destination for news from Express Pharma. See how Express Pharma’s media bias impacts the breaking news stories of today. We’ve aggregated 210 of Express Pharma’s headlines and news stories over the past 3 months. Ground News rates Express Pharma’s media bias as . . Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check. Express Pharma’s factuality rating is Unknown. Ground News calculates this rating using a combination of the fact and reliability ratings from Ad Fontes Media and Media Bias/Fact Check. Information about Express PharmaWhere is Express Pharma located?Express Pharma's WebsiteMedia Bias RatingsDo you diasgree? Edit biasLearn more about Media Bias Ratings.FactualityAverage Factuality Rating: UnknownLearn more about Factuality Ratings.Top Express Pharma NewsMumbai · Mumbai360 ONE Asset acquires share in OneSourceThe rapidly expanding and highly specialised pharmaceutical CDMO (Contract Development and Manufacturing Organisation) in India, OneSource Specialty Pharma, has acquired a stake by 360 ONE Asset, one of the country’s asset management companies. At a critical juncture in OneSource’s development, 360 ONE Asset is purchasing a stake from an existing investor as the business moves closer to its goal of becoming a major force in the fields of biologi…See the StoryMaryland · MarylandDr Jitendra Singh announces soft launch of first indigenous antibiotic, Nafithromycin, to combat AMR - Express HealthcareUnion Minister Dr Jitendra Singh formally launched the first indigenous antibiotic “Nafithromycin” for resistant infections. It is only after 2014, when Prime Minister Narendra Modi took over that our researchers received the right kind of support to explore their potential, said Dr Jitendra Singh. The antibiotic Nafithromycin has been developed with the support of the Biotechnology Industry Research Assistance Council (BIRAC), a unit of the Dep…See the StoryGenpact extends partnership with Ferring Pharmaceuticals to enhance operations - Express PharmaGenpact, a global professional services and solutions firm, has announced the extension of its partnership with Ferring Pharmaceuticals, a research-driven biopharmaceutical company. The multi-year agreement aims to continue transforming Ferring’s finance, accounting, and procurement operations through advanced technologies, including artificial intelligence (AI). Sanjiv Tandon, Global Head of Life Sciences and Healthcare at Genpact, stated, “To …See the StoryLatest News StoriesTopics Most Covered by Express PharmaHealthcareInnovationVaccinesAstraZenecaEli LillyHealthcareInnovationVaccinesSources Covering Similar TopicsGlobalDataExpress HealthcareLupinIndia Education DiaryTHIP MediaGlobalDataExpress HealthcareLupinSuggest a sourceLooking for a source we don't already have? Suggest one here.You've scrolled to the bottom of the feed, there are no more stories.
